| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 161.18 | 11.3% | 12.0% |
| Total Income | 161.18 | 11.3% | 12.0% |
| Expenditure | 165.36 | 46.8% | 14.3% |
| PBT | 0.85 | 100.5% | 75.3% |
| Net Profit | 2.46 | 101.5% | 104.7% |
| OPM | -2.59% | 2.10pp | |
| NPM | 1.52% | 38.21pp | |
| EPS | 0.05 | 101.4% | 104.3% |
Azenta Reports Q3 2026 Results, Revenue Up 12% YoY
05 Aug 2026 · 5 Aug, 2:10 am
Summary
Azenta, Inc. announced its third quarter fiscal 2026 results, with revenue from continuing operations reaching $161 million, up 12% year over year. Organic revenue also saw a healthy 9% increase, primarily driven by the Sample Management Solutions and Multiomics segments. The company reported an Adjusted EBITDA of $18.5 million for continuing operations, a 6% rise compared to the prior year. Looking ahead, Azenta now anticipates full year fiscal 2026 reported revenue to be between $613 million and $618 million, with Adjusted EBITDA projected to be between $59 million and $62 million.
Key Highlights
- 1
Azenta reported third quarter revenue of $161 million, an increase of 12% year over year.
- 2
Organic revenue grew 9% year over year, driven by strength in Sample Management Solutions and Multiomics.
- 3
Sample Management Solutions revenue increased 14% year over year to $88 million.
- 4
Multiomics revenue grew 10% year over year to $73 million.
- 5
Adjusted EBITDA from continuing operations was $18.5 million, a 6% increase year over year.
- 6
The company now expects full year fiscal 2026 reported revenue from continuing operations to range between $613 million and $618 million.
- 7
Full year fiscal 2026 Adjusted EBITDA is expected to be in the range of $59 million to $62 million.
Management Comments
John Marotta
Despite an uneven and challenging market backdrop, our third quarter results exceeded our expectations, with continued strength in our recurring revenue businesses, and a modest improvement in Multiomics in North America. While these results represent an encouraging step forward, our turnaround continues, and we remain focused on executing against our strategic priorities.
Informational and educational content only. Not investment advice.